{"id":7324,"date":"2022-04-05T14:26:53","date_gmt":"2022-04-05T22:26:53","guid":{"rendered":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7324"},"modified":"2022-04-08T16:01:47","modified_gmt":"2022-04-09T00:01:47","slug":"monoclonal-antibodies-for-treating-severe-asthma","status":"publish","type":"post","link":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7324","title":{"rendered":"Monoclonal Antibodies for Treating Severe Asthma"},"content":{"rendered":"

Drug Info: ApoThera Drug Disease Clinical Support App<\/em><\/a><\/strong><\/p>\n

ApoThera Specialty Medications, Monoclonal Antibodies, Available for Treating Severe Asthma:
\n– Cinqair (Reslizumab)
\n– Dupixent (Dupilumab)
\n– Fasenra (Benralizumab)
\n– Tezspire (Tezepelumab)<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Drug Info: ApoThera Drug Disease Clinical Support App ApoThera Specialty Medications, Monoclonal Antibodies, Available for Treating Severe Asthma: – Cinqair (Reslizumab) – Dupixent (Dupilumab) – Fasenra (Benralizumab) – Tezspire (Tezepelumab)…<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[16],"tags":[278,289,284,297,266,287,286,288,279,285,267,281,280],"class_list":["post-7324","post","type-post","status-publish","format-standard","hentry","category-blog","tag-asthma","tag-benralizumab","tag-cinqair","tag-clinical-decision-support","tag-drug-information","tag-dupilumab","tag-dupixent","tag-fasenra","tag-monoclonal-antibody","tag-reslizumab","tag-specialty-pharmacy","tag-tezepelumab","tag-tezspire"],"jetpack_featured_media_url":"","jetpack-related-posts":[{"id":7301,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7301","url_meta":{"origin":7324,"position":0},"title":"Tezspire (Tezepelumab), Monoclonal Antibody for the Treatment of Severe Asthma","date":"April 5, 2022","format":false,"excerpt":"Drug Info: ApoThera Drug Disease Clinical Support App Severe Asthma - 210 mg SC every 4 weeks - Add-on maintenance treatment of severe asthma Missed Dose - Administer dose as soon as possible - Thereafter, resume dosing on the usual day of administration - If the next dose is already\u2026","rel":"","context":"In "Blog"","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":7530,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7530","url_meta":{"origin":7324,"position":1},"title":"Drug Information for COVID-19 Monoclonal Antibodies (Bebtelovimab) and Evusheld (Tixagevimab-Cilgavimab)","date":"April 8, 2022","format":"image","excerpt":"Drug Info: ApoThera Drug Disease Clinical Support App Drug Info: ApoThera Drug Disease Clinical Support App Drug Information for COVID-19 Monoclonal Antibodies (Bebtelovimab) and COVID-19 Polyclonal Antibody Evusheld (Tixagevimab-Cilgavimab) Available on ApoThera Clinical Decision Support Mobile \u00a0","rel":"","context":"In "Blog"","img":{"alt_text":"","src":"https:\/\/i0.wp.com\/store.apotheraspecialtypharmacy.com\/wp-content\/uploads\/2022\/04\/COVID.19.Viral_.Replication.and_.Symptom.Onset_.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":7374,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7374","url_meta":{"origin":7324,"position":2},"title":"FDA Pulls Authorization for GSK-Vir’s COVID Therapy, Sotrovimab, as BA.2 Cases Rise","date":"April 6, 2022","format":false,"excerpt":"The U.S. health regulator said on Tuesday GlaxoSmithKline (GSK.L) and Vir Biotechnology's (VIR.O) antibody therapy was no longer authorized as a COVID-19 treatment, with data suggesting it was unlikely to be effective against the dominant Omicron sub-variant in the country. Drug Information for COVID-19 Monoclonal Antibody (Bebtelovimab) and COVID-19 Polyclonal\u2026","rel":"","context":"In "Blog"","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":7212,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7212","url_meta":{"origin":7324,"position":3},"title":"Rinvoq (upadacitinib) New Indications: Treatment of Moderate-to-Severe Ulcerative Colitis (UC)","date":"April 4, 2022","format":false,"excerpt":"Drug Info: ApoThera Drug Disease Clinical Support App Rinvoq (upadacitinib) receives FDA approval for the treatment of adults with moderately to severely active Ulcerative Colitis (UC) Induction Dose - 45 mg by mouth daily x 8 weeks Maintenance Dose - 15 mg by mouth daily - Use lowest effective dosage\u2026","rel":"","context":"In "Blog"","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":7766,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7766","url_meta":{"origin":7324,"position":4},"title":"FDA Approves Igalmi (Dexmedetomidine) Sublingual Film","date":"April 16, 2022","format":false,"excerpt":"Drug Info: ApoThera Drug Disease Clinical Support App - Assess vital signs including orthostatic measurements before administering Mild or Moderate\u00a0Schizophrenia Agitation - 120 mcg SL or BUC x 1 dose - May give additional 60 mcg for up to 2 doses at least 2 hour apart - Maximum Dose: 240\u2026","rel":"","context":"In "Blog"","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":7542,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7542","url_meta":{"origin":7324,"position":5},"title":"Drug Information for Paxlovid (Nirmatrelvir-Ritonavir), Oral Medications for the Treatment of Mild-to-Moderate COVID-19, Available on ApoThera Clinical Decision Support Mobile Application","date":"April 9, 2022","format":false,"excerpt":"Drug Info: ApoThera Drug Disease Clinical Support App Nirmatrelvir-Ritonavir (Paxlovid) - 300 mg nirmatrelvir + 100 mg Ritonavir by mouth twice daily x 5 days - Initiate as soon as possible after COVID-19 diagnosis and within 5 days of symptom onset - Completing the full 5-day treatment course and isolate\u2026","rel":"","context":"In "Blog"","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/posts\/7324","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7324"}],"version-history":[{"count":1,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/posts\/7324\/revisions"}],"predecessor-version":[{"id":7325,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/posts\/7324\/revisions\/7325"}],"wp:attachment":[{"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7324"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7324"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7324"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}